Developing New Approaches to Clinical Data & Evidence Generation to Demonstrate Initial Benefit & Support Long Term Follow Up

06 Sep 2023
15:30
SPONSORED BY
TITLE21 Health Solutions

15:30pm Chair Introduction

To be Confirmed

 

15:35pm Presentation: Title to be Confirmed

  • Bulletpoint 1
  • Bulletpoint 2
  • Bulletpoint 3

Michael Von Forstner, Senior Medical Director, Global Head of Patient Safety and Pharmacovigilance, Biosimilars, Biogen 

 

15:50pm Presentation: Title to be Confirmed

  • Bulletpoint 1
  • Bulletpoint 2
  • Bulletpoint 3

Senior Representative, Title21

 

16:05 Presentation: Title to be Confirmed

  • Bulletpoint 1
  • Bulletpoint 2
  • Bulletpoint 3

Presenter to be Confirmed

 

16:20pm Presentation: Title to be Confirmed

  • Bulletpoint 1
  • Bulletpoint 2
  • Bulletpoint 3

Presenter to be Confirmed

 

16:35pm Closing Panel with Q&A

With all session participants

Speakers

Michael von Forstner
Senior Medical Director, Global Head of Patient Safety and Pharmacovigilance, Biosimilars
Biogen